Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lurie

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
JAMA Health Forum|October 9, 2025
Assault on the Centers for Disease Control and Prevention-Budget Cuts, Political Control, and the Erosion of TrustLawrence O Gostin, Peter Lurie
American Journal of Industrial Medicine|October 17, 2002
Continuing exposure to hexavalent chromium, a known lung carcinogen: an analysis of OSHA compliance inspections, 1990-2000Peter Lurie, Sidney M Wolfe
JAMA|December 6, 2021
Product Approval and Public Health at the US Food and Drug AdministrationPeter Lurie, Joshua M Sharfstein
JAMA|October 22, 2025
The Make American Healthy Again Strategy ReportPeter Lurie, Lawrence O Gostin
Lancet (London, England)|October 11, 2005
Misleading data analyses in salmeterol (SMART) studyPeter Lurie, Sidney M Wolfe
Journal of Occupational and Environmental Medicine|October 13, 2006
Lung cancer mortality in the German chromate industry, 1958 to 1998David Michaels, Peter Lurie, Celeste Monforton
BMJ (Clinical Research Ed.)|July 30, 2002
The pharmaceutical industry and disease mongering. Déjà vu all over againMatthew Anderson, Alison Karasz, Peter Lurie
Environmental Health : a Global Access Science Source|March 1, 2006
Selected science: an industry campaign to undermine an OSHA hexavalent chromium standardDavid Michaels, Celeste Monforton, Peter Lurie
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
US Food and Drug Administration Efforts to Facilitate the Use of Expanded Access ProgramsTamy Kim, Peter Lurie, Richard Pazdur
Clinical Toxicology (Philadelphia, Pa.)|January 13, 2021
Opioid exposure associated with poppy consumption reported to poison control centers and the U.S. Food and Drug AdministrationEva Greenthal, Peter Lurie, Suzanne Doyon
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
JAMA Health Forum|October 9, 2025
Assault on the Centers for Disease Control and Prevention-Budget Cuts, Political Control, and the Erosion of TrustLawrence O Gostin, Peter Lurie
American Journal of Industrial Medicine|October 17, 2002
Continuing exposure to hexavalent chromium, a known lung carcinogen: an analysis of OSHA compliance inspections, 1990-2000Peter Lurie, Sidney M Wolfe
JAMA|December 6, 2021
Product Approval and Public Health at the US Food and Drug AdministrationPeter Lurie, Joshua M Sharfstein
JAMA|October 22, 2025
The Make American Healthy Again Strategy ReportPeter Lurie, Lawrence O Gostin
Lancet (London, England)|October 11, 2005
Misleading data analyses in salmeterol (SMART) studyPeter Lurie, Sidney M Wolfe
Journal of Occupational and Environmental Medicine|October 13, 2006
Lung cancer mortality in the German chromate industry, 1958 to 1998David Michaels, Peter Lurie, Celeste Monforton
BMJ (Clinical Research Ed.)|July 30, 2002
The pharmaceutical industry and disease mongering. Déjà vu all over againMatthew Anderson, Alison Karasz, Peter Lurie
Environmental Health : a Global Access Science Source|March 1, 2006
Selected science: an industry campaign to undermine an OSHA hexavalent chromium standardDavid Michaels, Celeste Monforton, Peter Lurie
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
US Food and Drug Administration Efforts to Facilitate the Use of Expanded Access ProgramsTamy Kim, Peter Lurie, Richard Pazdur
Clinical Toxicology (Philadelphia, Pa.)|January 13, 2021
Opioid exposure associated with poppy consumption reported to poison control centers and the U.S. Food and Drug AdministrationEva Greenthal, Peter Lurie, Suzanne Doyon
Pageof 8